{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-004293","form_type":"8-K","ticker":"SNTI","cik":"0001854270","company_name":"Senti Biosciences, Inc.","filed_at":"2025-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.321199+00:00","generated_at":"2026-05-27T01:50:35.811382+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Senti Biosciences CFO Yvonne Li departs; transition consultant through March 31","bullets":["Yvonne Li's consulting agreement as Interim CFO expired Jan 31, 2025; she ceased as principal financial and accounting officer.","Entered new consulting agreement on Feb 5, 2025 for transition support until March 31, 2025.","No permanent CFO appointment announced; Li will cooperate with executive management on orderly handover."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-004293","json":"https://secwatch.observer/filing/0001628280-25-004293.json","markdown":"https://secwatch.observer/filing/0001628280-25-004293.md","text":"https://secwatch.observer/filing/0001628280-25-004293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854270/000162828025004293/0001628280-25-004293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854270/000162828025004293/snti-20250131.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T01:50:35.811382+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"79b6963855","claim":"Yvonne Li departed as Interim Chief Financial Officer at Senti Biosciences, Inc..","evidence_excerpt":"On January 31, 2025, Yvonne Li, the Consulting Agreement by and between Senti Biosciences, Inc. (the “Company”) and Yvonne Li, the Company’s Interim Chief Financial Officer, expired in accordance with its terms.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828025004293/0001628280-25-004293-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Interim Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}